Hypoalgesic Effect of Neural Mobilization Versus Ibuprofen Pharmacologic Treatment

• Register: ClinicalTrials.gov
• Last refreshed on: 16 December 2017
• Main ID: NCT02593721
• Date of registration: 26/10/2015
• Prospective Registration: No
• Primary sponsor: Universidad Europea de Madrid
• Public title: Hypoalgesic Effect of Neural Mobilization Versus Ibuprofen Pharmacologic Treatment
• Scientific title: Hypoalgesic Effect of Median Nerve Neural Mobilization Versus Ibuprofen Pharmacologic Treatment in Patients With Cervicobrachial Pain
• Date of first enrolment: July 2015
• Target sample size: 50
• Recruitment status: Completed
• URL: https://clinicaltrials.gov/show/NCT02593721
• Study type: Interventional
• Study design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Investigator, Outcomes Assessor).
• Phase: Phase 2/Phase 3

Countries of recruitment

Venezuela

Contacts

• Name: Francisco H Unda, PT, MSc
• Affiliation: Universidad Europea de Madrid

Key inclusion & exclusion criteria

Inclusion Criteria:

- Clinical diagnosis of cervicobrachial pain confirmed by magnetic resonance imaging

- Presence of unilateral symptoms of arm pain, paresthesia or numbness in the upper
extremity during at least 3 continuous months previous to the application of
treatment.

- Positive results in all of the following tests: Spurling, Distraction, and Upper Limb

Exclusion Criteria:

- Contraindication in the use of nonsteroidal anti inflammatory drugs (NSAIDs)

- The use of any type of treatment, therapy, procedure or drug to relieve pain

- Patients who are under anticonvulsant, antidepressant or psychotropic medication

- Vertebral instability

- Vertebral osteoporosis

- Vertebral or spine infection.

- Neurologic diseases of genetic, infectious or neoplastic origin

- Cervical stenosis myelopathy

- Pregnancy

- Kinesiophobia

- Endocrine disorders and menopause

- History of spine surgery

- Intellectual disability, severe mental illness, intoxication, severe sleep
deprivation, Alzheimer's disease.



Age minimum: 18 Years
Age maximum: 45 Years
Gender: All

Health Condition(s) or Problem(s) studied

Cervicobrachial Neuralgia

Intervention(s)

Procedure: Median Nerve Neural Mobilization

Drug: Ibuprofen

Primary Outcome(s)

Change from baseline using the Numeric Rating Scale for Pain at 1 hour [Time Frame: at baseline and 1 hour after the application of treatment, corresponding to intervention sessions 1, 15 and 30]

Secondary Outcome(s)

Change from baseline cervical rotation range of motion at 1 hour [Time Frame: at baseline and 1 hour after the application of treatment, corresponding to intervention sessions 1 and 30]

Change from baseline of the Physical function involving the affected upper limb using the Quik DASH Scale [Time Frame: at baseline, corresponding to intervention session 1 and 30 of treatment.]

Secondary ID(s)

CE0072015

Source(s) of Monetary Support

Please refer to primary and secondary sponsors